Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Adlai Nortye Ltd.
Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
August 08, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
August 08, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
May 23, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
May 22, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
March 29, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
November 17, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
October 23, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
October 03, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
September 29, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Tickers
ANL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.